Related Experiment Video
Updated: Aug 15, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages
Mark W Feinberg1, Zhuoxiao Cao, Akm Khyrul Wara
1Program in Cardiovascular Transcriptional Biology, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. mfeinberg@rics.bwh.harvard.edu
Abstract:
Activation of macrophages is important in chronic inflammatory disease states such as atherosclerosis. Proinflammatory cytokines such as interferon-gamma (IFN-gamma), lipopolysaccharide (LPS), or tumor necrosis factor-alpha can promote macrophage activation. Conversely, anti-inflammatory factors such as transforming growth factor-beta1 (TGF-beta1) can decrease proinflammatory activation. The molecular mediators regulating the balance of these opposing effectors remain incompletely understood. Herein, we identify Kruppel-like factor 4 (KLF4) as being markedly induced in response to IFN-gamma, LPS, or tumor necrosis factor-alpha and decreased by TGF-beta1 in macrophages. Overexpression of KLF4 in J774a macrophages induced the macrophage activation marker inducible nitric-oxide synthase and inhibited the TGF-beta1 and Smad3 target gene plasminogen activator inhibitor-1 (PAI-1). Conversely, KLF4 knockdown markedly attenuated the ability of IFN-gamma, LPS, or IFN-gamma plus LPS to induce the iNOS promoter, whereas it augmented macrophage responsiveness to TGF-beta1 and Smad3 signaling. The KLF4 induction of the iNOS promoter is mediated by two KLF DNA-binding sites at -95 and -212 bp, and mutation of these sites diminished induction by IFN-gamma and LPS. We further provide evidence that KLF4 interacts with the NF-kappaB family member p65 (RelA) to cooperatively induce the iNOS promoter. In contrast, KLF4 inhibited the TGF-beta1/Smad3 induction of the PAI-1 promoter independent of KLF4 DNA binding through a novel antagonistic competition with Smad3 for the C terminus of the coactivator p300/CBP. These findings support an important role for KLF4 as a regulator of key signaling pathways that control macrophage activation.
Insights
Kruppel-like factor 4 (KLF4) regulates macrophage activation by balancing pro-inflammatory and anti-inflammatory signals. This study identifies KLF4 as a key mediator in chronic inflammatory diseases like atherosclerosis.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Macrophage activation is crucial in chronic inflammatory diseases, including atherosclerosis.
- Pro-inflammatory cytokines (interferon-gamma, lipopolysaccharide, tumor necrosis factor-alpha) promote activation, while anti-inflammatory factors (transforming growth factor-beta1) suppress it.
- The molecular regulators balancing these opposing pathways are not fully understood.
Purpose of the Study:
- To identify novel molecular mediators that regulate the balance between pro-inflammatory and anti-inflammatory signaling in macrophages.
- To elucidate the role of Kruppel-like factor 4 (KLF4) in controlling macrophage activation pathways.
Main Methods:
- Investigated KLF4 expression in response to various cytokines in macrophages.
- Utilized gene overexpression and knockdown techniques to assess KLF4's functional impact on macrophage activation markers (inducible nitric-oxide synthase - iNOS) and cytokine signaling pathways (TGF-beta1/Smad3).
- Analyzed KLF4's interaction with signaling proteins (p65/RelA, Smad3) and its effect on gene promoter activity (iNOS, plasminogen activator inhibitor-1 - PAI-1).
Main Results:
- KLF4 expression is induced by pro-inflammatory stimuli (IFN-gamma, LPS, TNF-alpha) and suppressed by TGF-beta1.
- KLF4 overexpression activates the iNOS promoter and inhibits the TGF-beta1/Smad3-mediated PAI-1 promoter.
- KLF4 knockdown attenuates pro-inflammatory induction of iNOS and enhances TGF-beta1/Smad3 signaling.
- KLF4 interacts with p65/RelA to induce the iNOS promoter and antagonizes Smad3 for p300/CBP to inhibit PAI-1 induction.
Conclusions:
- KLF4 is a critical regulator of macrophage activation, integrating pro-inflammatory and anti-inflammatory signals.
- KLF4 plays a significant role in pathways relevant to chronic inflammatory conditions like atherosclerosis.
- KLF4's distinct mechanisms of action on iNOS and PAI-1 promoters highlight its complex regulatory function.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease III: Crohn's Disease
The JAK-STAT Signaling Pathway
NF-kB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
